Long-term effects of beta blocker therapy on P-wave duration and dispersion in congestive heart failure patients: A new effect?

Journal of Electrocardiology

Volumn 36, Issue 2, 2003, Pages 111-116

  Çamsari, Ahmet ^a   Pekdemir, Hasan ^b   Akkus, M Necdet ^b   Yenihan, Senay ^b   Döven, Oben ^b   Cin, V Gökhan ^b  

^a MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE

Author keywords

Beta blocker; Heart failure; P wave dispersion; P wave duration

Indexed keywords

BELOC ZOK; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXIMUM TOLERATED DOSE; MORBIDITY; MORTALITY; P WAVE; P WAVE DISPERSION; P WAVE MAXIMUM DURATION; PRIORITY JOURNAL;

EID: 0037675006     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1054/jelc.2003.50020     Document Type: Article

References (23)

1. Alpert JS, Petersen P, Godtfredsen J: Atrial fibrillation: Natural history, complications and management. Ann Rev Med 39:41, 1988
2. Flaker GC, Blackshear JL, Mc Bride R, et al: Predictors of thromboembolism in atrial fibrillation: Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators. Ann Intern Med 116:1, 1992
3. Middlekauff HR, Stevenson WG, Stevenson LW: Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation 84:40, 1991
4. Tsikouris JP, Kluger J, Song J, et al: Changes in P-wave dispersion and P-wave duration after open heart surgery are associated with the peak incidence of atrial fibrillation. Heart Lung 30:466, 2001
5. Aytemir K, Ozer N, Atalar E, et al: P wave dispersion on 12-lead electrocardiography in patients with paroxismal atrial fibrillation. Pacing Clin Electrophysiol 23:1109, 2000
6. Tukek T, Akkaya V, Atilgan D, et al: Effect of left atrial size and function on P-wave dispersion: a study in patients with paroxismal atrial fibrillation. Clin Cardiol 24:676, 2001
7. Bristow MR, Gilbert EM, Abraham WT, et al: For the MOCHA Investigators. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 94:2807, 1996
8. CIBIS-II Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-II): A randomised trial. Lancet 353:9, 1999
9. MERIT-HF Study group: Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart failure (MERIT-HF). Lancet 353:2001, 1999
10. Ryden L, Kristensson BE, Westergren G: Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets. Eur J Clin Pharmacol 33:S33, 1988 (suppl)
11. Kawano S, Hiraoka M, Sawanobori T: Electrocardiographic features of p waves from patients with transient atrial fibrillation. Jpn Heart J 29:57, 1988
12. Dilaveris E, Giafalos EJ, Sideris SK, et al: Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733, 1998
13. Shan DJ, De Mario Kislo, et al: The committee on M-mode standardisation of America society of Echocardiography. Circulation 158:1072, 1978
14. Quinones MA, Pickering E, Alexander JK: Percentage of shortening of the echocardiographic left ventricular dimension: Its use in determining ejection fraction and stroke volume. Chest 74:59, 1978
15. Kannel WB, Wolf PA: Epidemiology of atrial fibrillation, in RH Falk, PJ Podrid (eds): Atrial fibrillation. Mechanisms and Management. New York, NY, Raven Press Ltd, 1992, p 81
16. Allessie MA, Bonke FIM, Schopman FJG: Circus movement in rabbit atrial muscle as a mechanism of tachycardia. The role of nonuniform recovery of excitability in the occurrance of unidirectional block as studied with multiple electrodes. Circ Res 39:168, 1976
17. Dilaveris PE: P-wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159, 2001
18. Ozmen F, Atalar E, Aytemir K, et al: Effect of balloon-induced acute ischaemia on P wave dispersion during percutaneous transluminal coronary angioplasty. Europace 3:299, 2001
19. Ho TF, Chia EL, Yip WC, et al: Analysis of p wave and p dispersion in children with secundum atrial septal defect. Ann Noninvasive Electrocardiol 6:305, 2001
20. Eichhron EJ, Bristow MR: Medical therapy can improve the biologic properties of the chronically failing heart: A new era in the treatment of the heart failure. Circulation 94:2285, 1996
21. Waagstein F, Bristow MR, Swedberg K, et al: For the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441, 1993
22. Song J, Kalus SJ, Caron MF, et al: Effect of diuresis on p wave duration and dispersion. Pharmacotherapy 22:564, 2002
23. Gersh BJ, Braunwald E, Bonow RO: Chronic coronary artery disease, in Braunwald E, Zipes DP, Libby P (eds): Heart Disease: A Textbook of Cardiovascular Medicine (ed 6). Philadelphia, PA, Saunders, 2001, p 1290